1. Benza, RL, Miller, DP, Gomberg-Maitland, M, et al. Predicting survival in pulmonary arterial hypertension: insights from the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL). Circulation 2010; 122: 164–172.
Google Scholar | Crossref | Medline | ISI2. Thenappan, T, Shah, SJ, Rich, S, et al. Survival in pulmonary arterial hypertension: a reappraisal of the NIH risk stratification equation. Eur Respir J 2010; 35: 1079–1087.
Google Scholar | Crossref | Medline | ISI3. Xu, W, Janocha, AJ, Erzurum, SC. Metabolism in pulmonary hypertension. Annu Rev Physiol 2021; 83: 551–576.
Google Scholar | Crossref | Medline4. Fessel, JP, Hamid, R, Wittmann, BM, et al. Metabolomic analysis of bone morphogenetic protein receptor type 2 mutations in human pulmonary endothelium reveals widespread metabolic reprogramming. Pulm Circ 2012; 2: 201–213.
Google Scholar | SAGE Journals5. Rhodes, CJ, Ghataorhe, P, Wharton, J, et al. Plasma metabolomics implicates modified transfer RNAs and altered bioenergetics in the outcomes of pulmonary arterial hypertension. Circulation 2017; 135: 460–475.
Google Scholar | Crossref | Medline6. Zhao, Y, Peng, J, Lu, C, et al. Metabolomic heterogeneity of pulmonary arterial hypertension. PLoS One 2014; 9: e88727.
Google Scholar | Crossref | Medline | ISI7. Zhao, YD, Chu, L, Lin, K, et al. A biochemical approach to understand the pathogenesis of advanced pulmonary arterial hypertension: metabolomic profiles of arginine, sphingosine-1-phosphate, and heme of human lung. PLoS One 2015; 10: e0134958.
Google Scholar | Crossref | Medline | ISI8. Hernandez-Saavedra, D, Sanders, L, Freeman, S, et al. Stable isotope metabolomics of pulmonary artery smooth muscle and endothelial cells in pulmonary hypertension and with TGF-beta treatment. Sci Rep 2020; 10: 413.
Google Scholar | Crossref | Medline9. Xu, W, Comhair, SAA, Chen, R, et al. Integrative proteomics and phosphoproteomics in pulmonary arterial hypertension. Sci Rep 2019; 9: 18623.
Google Scholar | Crossref | Medline10. Brittain, EL, Talati, M, Fessel, JP, et al. Fatty acid metabolic defects and right ventricular lipotoxicity in human pulmonary arterial hypertension. Circulation 2016; 133: 1936–1944.
Google Scholar | Crossref | Medline | ISI11. Brittain, EL, Niswender, K, Agrawal, V, et al. Mechanistic phase II clinical trial of metformin in pulmonary arterial hypertension. J Am Heart Assoc 2020; 9: e018349.
Google Scholar | Crossref | Medline12. Farha, S, Saygin, D, Park, MM, et al. Pulmonary arterial hypertension treatment with carvedilol for heart failure: a randomized controlled trial. JCI Insight 2017; 2 e95240.
Google Scholar | Crossref | Medline | ISI13. Saygin, D, Highland, KB, Farha, S, et al. Metabolic and functional evaluation of the heart and lungs in pulmonary hypertension by gated 2-[18F]-fluoro-2-deoxy-D-glucose positron emission tomography. Pulm Circ 2017; 7: 428–438.
Google Scholar | SAGE Journals | ISI14. Comhair, SA, McDunn, J, Bennett, C, et al. Metabolomic endotype of asthma. J Immunol 2015; 195: 643–650.
Google Scholar | Crossref | Medline15. Evans, AM, DeHaven, CD, Barrett, T, et al. Integrated, nontargeted ultrahigh performance liquid chromatography/electrospray ionization tandem mass spectrometry platform for the identification and relative quantification of the small-molecule complement of biological systems. Anal Chem 2009; 81: 6656–6667.
Google Scholar | Crossref | Medline | ISI16. Kalhan, SC, Guo, L, Edmison, J, et al. Plasma metabolomic profile in nonalcoholic fatty liver disease. Metabolism 2011; 60: 404–413.
Google Scholar | Crossref | Medline | ISI17. Kalhan, SC, Gruca, LL, Parimi, PS, et al. Serine metabolism in human pregnancy. Am J Physiol Endocrinol Metab 2003; 284: E733–E740.
Google Scholar | Crossref | Medline18. Garda, HA, Arrese, EL, Soulages, JL. Structure of apolipophorin-III in discoidal lipoproteins. Interhelical distances in the lipid-bound state and conformational change upon binding to lipid. J Biol Chem 2002; 277: 19773–19782.
Google Scholar | Crossref | Medline19. Tang, WH, Tong, W, Shrestha, K, et al. Differential effects of arginine methylation on diastolic dysfunction and disease progression in patients with chronic systolic heart failure. Eur Heart J 2008; 29: 2506–2513.
Google Scholar | Crossref | Medline20. Mor-Avi, V, Lang, RM, Badano, LP, et al. Current and evolving echocardiographic techniques for the quantitative evaluation of cardiac mechanics: ASE/EAE consensus statement on methodology and indications endorsed by the Japanese Society of Echocardiography. J Am Soc Echocardiogr 2011; 24: 277–313.
Google Scholar | Crossref | Medline | ISI21. Pirat, B, McCulloch, ML, Zoghbi, WA. Evaluation of global and regional right ventricular systolic function in patients with pulmonary hypertension using a novel speckle tracking method. Am J Cardiol 2006; 98: 699–704.
Google Scholar | Crossref | Medline | ISI22. Puwanant, S, Park, M, Popovic, ZB, et al. Ventricular geometry, strain, and rotational mechanics in pulmonary hypertension. Circulation 2010; 121: 259–266.
Google Scholar | Crossref | Medline | ISI23. Rudski, LG, Lai, WW, Afilalo, J, et al. Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. J Am Soc Echocardiogr 2010; 23: 685–713; quiz 786–688.
Google Scholar | Crossref | Medline | ISI24. Sachdev, A, Villarraga, HR, Frantz, RP, et al. Right ventricular strain for prediction of survival in patients with pulmonary arterial hypertension. Chest 2011; 139: 1299–1309.
Google Scholar | Crossref | Medline | ISI25. Farha, S, Lundgrin, EL, Erzurum, SC. Novel therapeutic approaches to preserve the right ventricle. Curr Heart Fail Rep 2013; 10: 12–17.
Google Scholar | Crossref | Medline26. Benjamini, Y HY. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Series B 1995; 57(1): 289–300.
Google Scholar | Crossref27. Rolland, T, Tasan, M, Charloteaux, B, et al. A proteome-scale map of the human interactome network. Cell 2014; 159: 1212–1226.
Google Scholar | Crossref | Medline28. Rual, JF, Venkatesan, K, Hao, T, et al. Towards a proteome-scale map of the human protein-protein interaction network. Nature 2005; 437: 1173–1178.
Google Scholar | Crossref | Medline | ISI29. Cheng, F, Desai, RJ, Handy, DE, et al. Network-based approach to prediction and population-based validation of in silico drug repurposing. Nat Commun 2018; 9: 2691.
Google Scholar | Crossref | Medline30. Hu, J, Rho, HS, Newman, RH, et al. PhosphoNetworks: a database for human phosphorylation networks. Bioinformatics 2014; 30: 141–142.
Google Scholar | Crossref | Medline31. Cheng, F, Jia, P, Wang, Q, et al. Quantitative network mapping of the human kinome interactome reveals new clues for rational kinase inhibitor discovery and individualized cancer therapy. Oncotarget 2014; 5: 3697–3710.
Google Scholar | Crossref | Medline32. Keshava Prasad, TS, Goel, R, Kandasamy, K, et al. Human protein reference database – 2009 update. Nucleic Acids Res 2009; 37: D767–D772.
Google Scholar | Crossref | Medline | ISI33. Hornbeck, PV, Zhang, B, Murray, B, et al. PhosphoSitePlus, 2014: mutations, PTMs and recalibrations. Nucleic Acids Res 2015; 43: D512–D520.
Google Scholar | Crossref | Medline34. Lu, CT, Huang, KY, Su, MG, et al. DbPTM 3.0: an informative resource for investigating substrate site specificity and functional association of protein post-translational modifications. Nucleic Acids Res 2013; 41: D295–D305.
Google Scholar | Crossref | Medline35. Dinkel, H, Chica, C, Via, A, et al. Phospho.ELM: a database of phosphorylation sites–update 2011. Nucleic Acids Res 2011; 39: D261–D267.
Google Scholar | Crossref | Medline36. Oughtred, R, Stark, C, Breitkreutz, BJ, et al. The BioGRID interaction database: 2019 update. Nucleic Acids Res 2019; 47: D529–D541.
Google Scholar | Crossref | Medline37. Cowley, MJ, Pinese, M, Kassahn, KS, et al. PINA v2.0: mining interactome modules. Nucleic Acids Res 2012; 40: D862–D865.
Google Scholar | Crossref | Medline38. Meyer, MJ, Das, J, Wang, X, et al. INstruct: a database of high-quality 3D structurally resolved protein interactome networks. Bioinformatics 2013; 29: 1577–1579.
Google Scholar | Crossref | Medline39. Licata, L, Briganti, L, Peluso, D, et al. MINT, the molecular interaction database: 2012 update. Nucleic Acids Res 2012; 40: D857–D861.
Google Scholar | Crossref | Medline | ISI40. Orchard, S, Ammari, M, Aranda, B, et al. The MIntAct project–IntAct as a common curation platform for 11 molecular interaction databases. Nucleic Acids Res 2014; 42: D358–D363.
Google Scholar | Crossref | Medline41. Breuer, K, Foroushani, AK, Laird, MR, et al. InnateDB: systems biology of innate immunity and beyond–recent updates and continuing curation. Nucleic Acids Res 2013; 41: D1228–D1233.
Google Scholar | Crossref | Medline | ISI42. Csabai, L, Olbei, M, Budd, A, et al. SignaLink: multilayered regulatory networks. Methods Mol Biol 2018; 1819: 53–73.
Google Scholar | Crossref | Medline43. Huttlin, EL, Ting, L, Bruckner, RJ, et al. The BioPlex network: a systematic exploration of the human interactome. Cell 2015; 162: 425–440.
Google Scholar | Crossref | Medline44. Cheng, F, Kovacs, IA, Barabasi, AL. Network-based prediction of drug combinations. Nat Commun 2019; 10: 1197.
Google Scholar | Crossref | Medline45. Kanehisa, M, Sato, Y, Furumichi, M, et al. New approach for understanding genome variations in KEGG. Nucleic Acids Res 2019; 47: D590–D595.
Google Scholar | Crossref | Medline46. Brunk, E, Sahoo, S, Zielinski, DC, et al. Recon3D enables a three-dimensional view of gene variation in human metabolism. Nat Biotechnol 2018; 36: 272–281.
Google Scholar | Crossref | Medline47. Pornputtapong, N, Nookaew, I, Nielsen, J. Human metabolic atlas: an online resource for human metabolism. Database (Oxford) 2015; 2015: bav068.
Google Scholar |